表示1–915结果
5-Amino-1MQ is a small-molecule research compound recognized for its role as a selective nicotinamide N-methyltransferase (NNMT) inhibitor. In preclinical metabolic studies, 5-Amino-1MQ has been shown to support NAD⁺ salvage pathway activity, which may contribute to improved cellular energy balance and enhanced sirtuin signaling.
Epitalon (Epithalon, AEDG) is a synthetic tetrapeptide consisting of four amino acids (Ala-Glu-Asp-Gly) based on a naturally occurring pineal gland peptide. Developed by Russian scientist Vladimir Khavinson and studied for over 35 years, Epitalon is primarily researched for its ability to activate telomerase, extend telomeres, and potentially slow cellular aging through multiple mechanisms including melatonin regulation and gene expression modulation.
GHK-Cu is a research peptide–copper complex composed of the tripeptide Gly-His-Lys bound to copper (II) ions, widely studied for its role in cellular signaling and extracellular matrix modulation. Preclinical research suggests GHK-Cu may support collagen regulation, gene expression, and antioxidant enzyme activity through copper-mediated redox mechanisms, making it a key compound in tissue remodeling, metalloprotein regulation, and regenerative biochemistry research.
IGF-1 LR3 is a research peptide analog of human insulin-like growth factor-1 (IGF-1) featuring a 13-amino-acid N-terminal extension that improves stability and receptor affinity. In experimental models, IGF-1 LR3 activates the IGF-1 receptor, stimulating PI3K/Akt and MAPK/ERK signaling pathways involved in cell growth, differentiation, metabolic regulation, and anabolic signaling. It is widely used in research focused on receptor kinetics, tissue remodeling, and peptide-mediated growth mechanisms.
Ipamorelin is a synthetic pentapeptide growth hormone secretagogue that selectively activates the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor. In research models, Ipamorelin stimulates Gq/PLC-dependent calcium signaling to promote growth hormone release while showing minimal effect on other pituitary hormones such as ACTH, cortisol, prolactin, FSH, LH, and TSH. Its high receptor selectivity makes Ipamorelin a widely used compound in studies of somatotropic signaling, pituitary receptor pharmacology, and peptide-mediated tissue and musculoskeletal research.
The Klow Blend is a research peptide combination that includes BPC-157 10mg, TB-500 10mg, KPV 10mg, and GHK-Cu 50mg, formulated for studies focused on cellular repair, immune modulation, and extracellular matrix regulation. BPC-157 supports nitric oxide and growth factor signaling, TB-500 influences actin dynamics and tissue remodeling, KPV modulates NF-κB and cytokine pathways, and GHK-Cu regulates metalloprotein activity and redox balance. Together, the Klow Blend is widely used in research exploring regeneration, inflammation control, and peptide–metal interaction mechanisms.
MOTS-c is a mitochondria-derived research peptide composed of 16 amino acids and encoded within the mitochondrial 12S rRNA gene. Preclinical studies show that MOTS-c plays a role in cellular metabolism and mitochondrial homeostasis by activating AMPK signaling pathways. Due to its unique mitochondrial origin, MOTS-c is widely used in metabolic, aging, and energy regulation research, particularly in studies focused on stress adaptation and mitochondrial signaling mechanisms.
NAD⁺ (nicotinamide adenine dinucleotide) is an essential cellular coenzyme that plays a central role in redox metabolism and energy production. It functions as a key electron carrier, cycling between NAD⁺ and NADH to support mitochondrial oxidative phosphorylation and glycolytic energy transfer in experimental models. Beyond metabolism, NAD⁺ acts as a required substrate for sirtuins and PARP enzymes, which are involved in DNA repair, gene expression, cellular stress response, and aging-related pathways. As a result, NAD⁺ is widely used in research focused on mitochondrial health, muscle metabolism, neuroprotection, cellular resilience, and longevity mechanisms.
Retatrutide 10 mg is a next-generation triple-agonist peptide developed by Eli Lilly that simultaneously activates GLP-1, GIP, and glucagon receptors. This advanced multi-receptor approach distinguishes retatrutide from earlier weight-management compounds by targeting appetite control, insulin regulation, energy expenditure, and fat oxidation together, making it a key focus in metabolic and obesity research.
结束的内容
结束的内容
没有一个帐户吗？ 注册
